Author Correction: Target deconvolution of HDAC pharmacopoeia reveals MBLAC2 as common off-target

Affiliations

• ¹ Chair of Proteomics and Bioanalytics, TUM School of Life Sciences, Technical University of Munich, Freising, Germany.
• ² Department of Molecular Medicine, College of Veterinary Medicine, Cornell University, Ithaca, New York, USA.
• ³ Animal Physiology and Immunology, TUM School of Life Sciences, Technical University of Munich, Freising, Germany.
• ⁴ Cancer Drug Development, German Cancer Research Center (DKFZ), Heidelberg, Germany.
• ⁵ Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.
• ⁶ Computational Mass Spectrometry, TUM School of Life Sciences, Technical University of Munich, Freising, Germany.
• ⁷ Institute of Pharmacy, Martin Luther University of Halle-Wittenberg, Halle (Saale), Germany.
• ⁸ LipiTUM, Chair of Experimental Bioinformatics, TUM School of Life Sciences, Technical University of Munich, Freising, Germany.
• ⁹ Bavarian Center for Biomolecular Mass Spectrometry (BayBioMS), Technical University of Munich, Freising, Germany.
• ¹⁰ German Cancer Consortium (DKTK), Heidelberg, Germany.
• ¹¹ Chair of Proteomics and Bioanalytics, TUM School of Life Sciences, Technical University of Munich, Freising, Germany. g.medard@tum.de.